NASDAQ$PRCT
PROCEPT BioRobotics Corporation · Q2 2025 earnings
Q2 2025 earnings · · After market close · Investor relations
Briefing
PROCEPT BioRobotics Corporation reported Q2 2025 revenue of $79.2 million, up 48% year-over-year.
The company achieved strong revenue growth driven by increased U.S. system placements and higher utilization of handpieces and consumables. Gross margin improved to 65% due to scale efficiencies. Net loss narrowed to $19.6 million as operating expenses grew at a slower pace than revenue.
- Q2 revenue reached $79.2 million, a 48% increase from $53.4 million in Q2 2024.
- U.S. revenue comprised 88% of total, with handpieces and consumables driving the majority of growth.
- Global installed base expanded to 762 robotic systems, including 595 in the United States.
- Cash and cash equivalents stood at $302.7 million with continued investment in commercial expansion.
Headline financials
Revenue & EPS history
PROCEPT BioRobotics · Revenue · Quarterly
$79.2M
Revenue by segment
PROCEPT BioRobotics · $79.2M total across 6 segments · Q2 2025
- U.S. Handpieces and Consumables$43.1M—54.5%
- U.S. System Sales and Rentals$22.1M—27.9%
- International Handpieces and Consumables$6M—7.6%
- U.S. Service$4.37M—5.5%
- International System Sales and Rentals$2.95M—3.7%
- International Service$650K—0.8%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports
+1.3%
Avg return
Earnings day
-0.2%
Avg return
5 days after
+0.6%
Avg return
30 days after
45%
10 / 22 earnings
Positive
+40.6%
Q3 2024
Best reaction
-15.2%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2025 | — | — | — | |
| Q1 2026 | +10.7% | +16.0% | +21.3% | |
| Q4 2025 | -15.2% | -5.7% | -5.3% | |
| Q3 2025 | +1.6% | -7.5% | +2.7% | |
| Q1 2025 | -5.6% | +1.1% | +3.0% | |
| Q4 2024 | +8.6% | -3.4% | -4.2% | |
| Q3 2024 | +40.6% | +34.2% | +41.5% | |
| Q2 2024 | -9.4% | -4.3% | +24.8% | |
| Q1 2024 | +16.5% | +15.9% | +25.3% | |
| Q4 2023 | +1.1% | +0.5% | +1.2% | |
| Q3 2023 | +21.7% | +22.5% | +39.5% | |
| Q2 2023 | -6.7% | -10.3% | -18.4% | |
| Q1 2023 | -15.0% | -20.1% | -10.9% | |
| Q4 2022 | +1.2% | -4.3% | -28.7% | |
| Q3 2022 | -9.9% | -8.4% | +5.8% | |
| Q2 2022 | +4.3% | +4.3% | +0.2% | |
| Q1 2022 | -5.1% | -17.9% | +19.5% | |
| Q4 2021 | +1.2% | +5.9% | +38.7% | |
| Q4 2020 | -2.2% | -4.5% | -28.0% | |
| Q2 2021 | -2.2% | -4.5% | -28.0% | |
| Q3 2020 | -2.2% | -4.5% | -28.0% | |
| Q1 2021 | -2.2% | -4.5% | -28.0% | |
| Q3 2021 | -4.4% | -3.9% | -29.6% | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro